CTCF values were measured for the two treatment categories and samples treated with 8 μM doxorubicin exhibited decreased tumor area compared to controls at 4 and 8 dpi (CTCF in RFU at 4 dpi (DMSO: 228.80, doxorubicin: 39.88), 8 dpi (DMSO: 253.63, doxorubicin: 29.90); Figure 4B). Here, CTCF is linked to neoplasm.